Inagene Logo.jpg
Canadians living with mental health conditions stand to save over $57 billion with use of pharmacogenetic testing
June 08, 2021 07:00 ET | Inagene Diagnostics Inc.
TORONTO, June 08, 2021 (GLOBE NEWSWIRE) -- Inagene Diagnostic Inc., a Canadian pharmacogenetic testing company, and Calian Group Ltd., one of Canada's largest national health services organizations,...
Dimensions Health Centres Announces Closing of First Treatment Center on Maple Lake in the Algonquin Highlands
May 25, 2021 08:30 ET | Dimensions Health Centres
TORONTO, May 25, 2021 (GLOBE NEWSWIRE) -- Dimensions Health Centres (“Dimensions”), a psychedelic treatment company focused on inpatient treatment integrating neuroscience with traditional healing...
Philogen logo.png
Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress
May 12, 2021 13:00 ET | Philogen
Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress May 12, 2021 NidlegyTM on track for Phase III European trial in stage IIIB/C melanoma. Opening of additional...
Healing Transitions Receives Grant from SECU Foundation to Expand Women’s Campus
May 10, 2021 13:11 ET | State Employees' Credit Union (SECU)
RALEIGH, N.C., May 10, 2021 (GLOBE NEWSWIRE) -- A local non-profit seeking to raise campaign funds for the renovation and much-needed expansion of campus facilities in Raleigh has received a...
Brain Scientific Announces Collaboration with JelikaLite in New Clinical Trial
March 16, 2021 08:30 ET | Brain Scientific Inc.
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, announces a collaboration...
Healthtech Solutions, Inc. (HLTT), Parent Company of Medi-Scan Inc., Announces Incorporation of a New Subsidiary Called RevHeart, Inc.
March 16, 2021 08:30 ET | Healthtech Solutions, Inc.
New subsidiary will further the Company’s research into treating COVID-related heart muscle injury.  A patent has been filed for a therapy to ameliorate and potentially repair myocardial damage. NEW...
Avra logo.jpg
AVRA Medical Robotics, Inc. (OTCMKTS: AVMR) 2020 Year-End CEO Update Letter to Shareholders and the Investment Community
February 11, 2021 09:30 ET | AVRA Medical Robotics, Inc.
ORLANDO, Fla., Feb. 11, 2021 (GLOBE NEWSWIRE) -- AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTCMKTS: AVMR) today issued the following update letter by its CEO, Barry Cohen to...
US Capital Global Securities Launches $7MM Preferred Stock Offering for Dianomi Therapeutics, Inc.
February 09, 2021 17:55 ET | US Capital Global
San Francisco, California, Feb. 09, 2021 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, an affiliate of US Capital Global, is offering to eligible investors an investment opportunity of up to...
HC2 Logo.jpg
HC2 Holdings Portfolio Company R2 Technologies Receives Final Tranche of $30 Million Investment
February 03, 2021 08:45 ET | HC2 Holdings, Inc.
NEW YORK, Feb. 03, 2021 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (“HC2” or “the Company”) (NYSE: HCHC) today announced that R2 Technologies Inc. ("R2"), founded by HC2’s portfolio company Pansend Life...
InvestorBrandNetwork Announces C3 Chat Show Podcast with CNS Pharmaceuticals Inc. Chairman and CEO John Climaco
January 13, 2021 08:30 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, Jan. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces...